RAPP Form 144: Sale of 2,840 Common Shares

RAPP filed a Form 144 reporting proposed resale activity in its Common Stock.

Rhea-AI Filing Summary

RAPP filed a Form 144 reporting proposed resale activity in its Common Stock. The filing lists an offering date of 05/20/2025 and a filing marker of 03/25/2026. The excerpt shows a reported sale of 2,840 Common shares on 12/31/2025 for $85,342.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does RAPP's Form 144 disclose about the transaction?

The Form 144 discloses a reported sale of 2,840 Common shares on 12/31/2025. It also lists an offering date of 05/20/2025 and a filing marker dated 03/25/2026, with proceeds shown as $85,342.

Who is listed in the filing related to the sale on RAPP's Form 144?

The excerpt lists KRISHNASWAMY with an address in Boston associated with the Common stock sale on 12/31/2025. A broker-dealer, Morgan Stanley Smith Barney LLC, appears under securities intermediary information in the filing excerpt.

What dates are shown on the RAPP Form 144 excerpt?

The excerpt shows an offering date of 05/20/2025, a reported sale date of 12/31/2025, and a filing marker of 03/25/2026. Those dates appear adjacent to the security and transaction lines in the provided content.

How much cash consideration is shown for the shares in RAPP's filing?

The filing excerpt shows aggregate proceeds of $85,342 tied to the reported sale of 2,840 Common shares on 12/31/2025. The excerpt pairs the share count and dollar amount on the sale line.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/25/2026 - 04:22 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002022156
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Rapport Therapeutics, Inc.
SEC File Number	001-42121
Address of Issuer	99 High Street, Suite 2100 Boston MASSACHUSETTS 02110
Phone	8573218020
Name of Person for Whose Account the Securities are To Be Sold	KRISHNASWAMY YELESWARAM
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10115	285748.75	47792943	03/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2025	Founders Shares	Issuer			10115	05/20/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KRISHNASWAMY YELESWARAM 99 High Street, Suite 2100 Boston MA 02110	Common	12/31/2025	2840	85342.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the acquisition of founders shares during the period of 05/20/2025 through 07/09/2025.
Date of Notice	03/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Krishnaswamy Yeleswaram
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)